| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Risk Officer | Director
2 companies
Debel Marlene serves as an EVP &Chief Risk Officer at MET and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 5 sells. Those positions are worth an estimated $14.3M at current prices.
Historically, Debel Marlene's trades have earned a middling insider score of 51/100 across 4 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -1.3%.
The biggest single holding is MET (~$14.3M) as EVP &Chief Risk Officer. The recent filings there lean toward selling, a net 68,573 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | MET Metlife, Inc. | EVP &Chief Risk Officer | Sale+OE | 21,312 | $81.59 | $1,738,822.64 | -12.1% | +16.3% | - | |
| Dec 13, 2024 | MET Metlife Inc | EVP &Chief Risk Officer | Sale+OE | 22,810 | $82.88 | $1,890,577.20 | -17.4% | -6.4% | -1.0% | |
| Aug 9, 2023 | MET Metlife Inc | EVP &Chief Risk Officer | Sale+OE | 9,391 | $63.18 | $593,323.38 | -10.8% | -4.1% | +11.2% | |
| Aug 19, 2022 | MET Metlife Inc | EVP &Chief Risk Officer | Sale+OE | 4,060 | $67.60 | $274,456.00 | -6.8% | +11.9% | -7.0% | |
| May 11, 2021 | MET Metlife Inc | EVP &Chief Risk Officer | Sell | 11,000 | $64.58 | $710,425.10 | -20.3% | -5.9% | +2.1% |